Recommendations—benefits and risks of T therapy . | LoE . | Grade . |
---|---|---|
Beyond 6 mo there is evidence of benefit for T therapy in body composition, bone mineralization, and features of metabolic syndrome | 3 | A |
T therapy improves sexual desire, erectile function, and sexual satisfaction | 1 | A |
Decreases in BMI and waist size and improved glycemic control and lipid profile are observed in hypogonadal men receiving T therapy | 2 | A |
Trials of T therapy should be ≥6 mo and maximal benefit is often seen beyond 12 mo | 2 | A |
Fully inform the patient about expected benefits and side effects of therapy and facilitate a joint decision by an informed patient and physician | 3 | A |
Fully discuss the adverse effect of T therapy and its future reversibility on future fertility for each patient and his partner and offer alternative treatment as necessary | 1b | B |
In patients with adult-onset TD, when T replacement therapy is prescribed, offer weight-loss and lifestyle advice as standard management | 2 | A |
In severely symptomatic patients with TT levels < 8 nmol/L, lifestyle and dietary advice alone is unlikely to produce meaningful clinical improvement within a relevant clinical period | 2 | B |
Recommendations—benefits and risks of T therapy . | LoE . | Grade . |
---|---|---|
Beyond 6 mo there is evidence of benefit for T therapy in body composition, bone mineralization, and features of metabolic syndrome | 3 | A |
T therapy improves sexual desire, erectile function, and sexual satisfaction | 1 | A |
Decreases in BMI and waist size and improved glycemic control and lipid profile are observed in hypogonadal men receiving T therapy | 2 | A |
Trials of T therapy should be ≥6 mo and maximal benefit is often seen beyond 12 mo | 2 | A |
Fully inform the patient about expected benefits and side effects of therapy and facilitate a joint decision by an informed patient and physician | 3 | A |
Fully discuss the adverse effect of T therapy and its future reversibility on future fertility for each patient and his partner and offer alternative treatment as necessary | 1b | B |
In patients with adult-onset TD, when T replacement therapy is prescribed, offer weight-loss and lifestyle advice as standard management | 2 | A |
In severely symptomatic patients with TT levels < 8 nmol/L, lifestyle and dietary advice alone is unlikely to produce meaningful clinical improvement within a relevant clinical period | 2 | B |
Recommendations—benefits and risks of T therapy . | LoE . | Grade . |
---|---|---|
Beyond 6 mo there is evidence of benefit for T therapy in body composition, bone mineralization, and features of metabolic syndrome | 3 | A |
T therapy improves sexual desire, erectile function, and sexual satisfaction | 1 | A |
Decreases in BMI and waist size and improved glycemic control and lipid profile are observed in hypogonadal men receiving T therapy | 2 | A |
Trials of T therapy should be ≥6 mo and maximal benefit is often seen beyond 12 mo | 2 | A |
Fully inform the patient about expected benefits and side effects of therapy and facilitate a joint decision by an informed patient and physician | 3 | A |
Fully discuss the adverse effect of T therapy and its future reversibility on future fertility for each patient and his partner and offer alternative treatment as necessary | 1b | B |
In patients with adult-onset TD, when T replacement therapy is prescribed, offer weight-loss and lifestyle advice as standard management | 2 | A |
In severely symptomatic patients with TT levels < 8 nmol/L, lifestyle and dietary advice alone is unlikely to produce meaningful clinical improvement within a relevant clinical period | 2 | B |
Recommendations—benefits and risks of T therapy . | LoE . | Grade . |
---|---|---|
Beyond 6 mo there is evidence of benefit for T therapy in body composition, bone mineralization, and features of metabolic syndrome | 3 | A |
T therapy improves sexual desire, erectile function, and sexual satisfaction | 1 | A |
Decreases in BMI and waist size and improved glycemic control and lipid profile are observed in hypogonadal men receiving T therapy | 2 | A |
Trials of T therapy should be ≥6 mo and maximal benefit is often seen beyond 12 mo | 2 | A |
Fully inform the patient about expected benefits and side effects of therapy and facilitate a joint decision by an informed patient and physician | 3 | A |
Fully discuss the adverse effect of T therapy and its future reversibility on future fertility for each patient and his partner and offer alternative treatment as necessary | 1b | B |
In patients with adult-onset TD, when T replacement therapy is prescribed, offer weight-loss and lifestyle advice as standard management | 2 | A |
In severely symptomatic patients with TT levels < 8 nmol/L, lifestyle and dietary advice alone is unlikely to produce meaningful clinical improvement within a relevant clinical period | 2 | B |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.